Physician profile
Lee J Buttaggi
NPI 1356322044
$2,062.94
in general payments reported to CMS, 2019-2025
21 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $260 · 2021: $417 · 2022: $247 · 2023: $188 · 2024: $259 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $250.54 | 2020-2025 | Cequa |
| Alcon Vision LLC | $220.17 | 2020-2025 | Rocklatan, Tryptyr, Total30 |
| Sight Sciences, INC. | $183.57 | 2021 | |
| Aerie Pharmaceuticals, INC. | $161.10 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $131.54 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $130.06 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Abbvie INC. | $126.34 | 2022-2025 | Lumigan |
| Coopervision INC. | $112.52 | 2019-2025 | Clariti Contact Lens |
| Biotissue Holdings INC. | $112.37 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $112.23 | 2019 | |
| Oyster Point Pharma, INC. | $101.37 | 2022-2024 | Tyrvaya |
| Genentech USA, INC. | $74.82 | 2024-2025 | Vabysmo |
| Thea Pharma INC. | $65.25 | 2023-2025 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $62.96 | 2024-2025 | Xdemvy |
| Menicon America INC | $50.73 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $39.24 | 2021-2025 | Oxervate |
| Allergan, INC. | $37.24 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $28.86 | 2020-2023 | Acuvue |
| Maculogix, INC. | $27.08 | 2020 | |
| Shire North American Group INC | $19.62 | 2019 | |
| Harrow Eye, LLC | $15.33 | 2025 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Buttaggi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.